Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -11.22% | -24.86% |
Mar. 18 | Harte Hanks, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Mar. 14 | Transcript : Harte Hanks, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Strengths
- With a P/E ratio at 14.16 for the current year and 6.81 for next year, earnings multiples are highly attractive compared with competitors.
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.17 for the 2024 fiscal year.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.86% | 51.81M | - | ||
-15.37% | 1.86B | B- | ||
-17.50% | 561M | - | - | |
+13.52% | 384M | - | - | |
-29.86% | 374M | - | - | |
+27.27% | 180M | C | ||
-54.23% | 101M | - | - | |
+71.93% | 94.08M | - | ||
+5.30% | 93.23M | - | - | |
-31.97% | 75.58M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- HHS Stock
- HRTH Stock
- Ratings Harte Hanks, Inc.